NeuroVive Pharmaceutical

Healthcare 📍 Lund, Sweden 👥 1-10 employees 💰 $10.8M raised 📅 Founded 2000

NeuroVive Pharmaceutical AB is a world leader in developing cyclosporine-based mitochondrial-protecting pharmaceuticals for the treatment of traumatic brain injuries (TBIs), reperfusion injury in myocardial infarction, stroke, and other acute injuries. Their advanced research program focuses on developing additional va

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

Sweden

Employees

1-10

Total Raised · Post-IPO

$10.8M

Founded

2000

Cloud

Unknown

Email

Mimecast

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Mimecast
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$18K – $45K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from NeuroVive Pharmaceutical's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction